MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome

    I. Aiba, M. Yoshida, T. Shimohata, Y. Hayashi, T. Sano, Y. Saito, S. Murayama, K. Hasegawa, Y. Iwasaki, M. Sakai, K. Wakabayashi, T. Komori, K. Nakashima (Nagoya, Japan)

    Objective: To compare clinical features and natural course of corticobasal degeneration (CBD) presenting as corticobasal syndrome (CBD-CBS) and progressive supranuclear palsy presenting as corticobasal syndrome…
  • MDS Virtual Congress 2020

    The Progressive Supranuclear Palsy Clinical Deficits Scale

    G. Respondek, I. Piot, K. Schweyer, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, T. Stebbins, G. Höglinger (Hannover, Germany)

    Objective: To develop a scale to monitor clinical deficits in patients with Progressive Supranuclear Palsy across its broad phenotypes. Background: There is currently no undisputed,…
  • MDS Virtual Congress 2020

    Atypical parkinsonism due to a mutation in the SLC9A6 gene

    L. Muñoz-Delgado, S. Jesús, D. Macías-García, A.D Adarmes-Gómez, F. Pérez-Errazquin, F. Carrillo, P. Mir (Seville, Spain)

    Objective: Expanding phenotypic spectrum in christianson syndrome (CS). Background: CS is an X-linked neurodevelopmental disorder characterized by intellectual disability combined with microcephaly, cognitive impairment, ataxia,…
  • MDS Virtual Congress 2020

    Multi-level and multi-pattern lower- and upper-limb spasticity treatment with incobotulinumtoxinA in children and adolescents with cerebral palsy

    E. Dabrowski, H. Chambers, F. Heinen, P. Kaňovský, S. Schroeder, M. Banach, H. Dersch, T. Geister, F. Martinez-Torres, I. Pulte, D. Gaebler-Spira (Royal Oak, MI, USA)

    Objective: Assess efficacy and safety of incobotulinumtoxinA in lower-limb (LL) or combined LL/upper-limb (LL/UL) spasticity in children and adolescents with cerebral palsy (CP). Background: Ambulant…
  • MDS Virtual Congress 2020

    Movement Disorders Analysis Using a Deep Learning Approach

    C. Desjardins, Q. Salardaine, G. Vignoud, B. Degos (Bobigny, France)

    Objective: Using a deep learning inspired approach, we developed a tool to compute an objective score of bradykinesia. Background: Bradykinesia is defined as a motor…
  • MDS Virtual Congress 2020

    SLC20A2 mutation manifesting as very-late onset orofacial dyskinesia

    K.A Woo, D. Yoo, B. Jeon, J.Y Lee (Seoul, Republic of Korea)

    Objective: We report two cases of genetically confirmed PFBC with a SLC20A2 mutation that presented with very-late onset orofacial dyskinesia. Background: Primary familial brain calcification…
  • MDS Virtual Congress 2020

    A Virtual Speech Therapist for Parkinson’s Disease

    A. Halpern, L. Ramig, R. Cole (Denver, CO, USA)

    Objective: This study was designed as a pilot investigation to explore the use of virtual therapy in the delivery of LSVT LOUD ® (Lee Silverman…
  • MDS Virtual Congress 2020

    Preferences for exercise in people with Parkinson’s disease: A discrete choice experiment

    S. Paul, C. Canning, N. Lofgren, C. Sherrington, D. Lee, J. Bampton, K. Howard (Sydney, Australia)

    Objective: To identify attributes of evidence-based exercise programs associated with the willingness of people with Parkinson’s disease (PD) to engage in additional exercise. Background: People…
  • MDS Virtual Congress 2020

    Quality of Life Study of Patients Living with Parkinson’s Disesae in Sub-Saharan Africa

    M. Fall, T.M Sarr (Dakar, Senegal)

    Objective: The objective is to assess the quality of life of patients with Parkinson's disease followed in Senegal. Background: Parkinson's disease is a neurodegenerative disease,…
  • MDS Virtual Congress 2020

    PKAN is associated with significant peripheral metabolic alterations in the Dominican Republic cohort

    C. Bass, F. Middleton, C. Muniz, A. Espinoza, M. Santana Jimenez, S. Baser (Pittsburgh, PA, USA)

    Objective: Applying segmental bioimpedance testing to assess peripheral metabolic alterations in PKAN. Background: PKAN is a rare autosomal recessive disorder with >50 different mutations in…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley